Upfront treatment with mTOR inhibitor everolimus in pediatric low‐grade gliomas: A single‐center experience
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upfront treatment with
mTOR
inhibitor everolimus in pediatric low‐grade gliomas: A single‐center experience
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-20
DOI
10.1002/ijc.33438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II study of oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study
- (2020) Nicole J Ullrich et al. NEURO-ONCOLOGY
- SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma
- (2019) Astrid K. Gnekow et al. KLINISCHE PADIATRIE
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
- (2019) Jason Fangusaro et al. LANCET ONCOLOGY
- Role of DNA Methylation Profile in Diagnosing Astroblastoma: A Case Report and Literature Review
- (2019) Giuseppe Petruzzellis et al. Frontiers in Genetics
- Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma
- (2019) Danielle S. Bitterman et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity
- (2019) Antje Arnold et al. NEURO-ONCOLOGY
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling
- (2018) G. Catanzaro et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- WHO 2016 Classification of gliomas
- (2018) P. Wesseling et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Role of mTOR Signaling in Tumor Microenvironment: An Overview
- (2018) Fabiana Conciatori et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trametinib for progressive pediatric low-grade gliomas
- (2018) Maria Kondyli et al. JOURNAL OF NEURO-ONCOLOGY
- FBXW7: a critical tumor suppressor of human cancers
- (2018) Chien-Hung Yeh et al. Molecular Cancer
- Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
- (2017) Yibing Yang et al. JNCI-Journal of the National Cancer Institute
- A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
- (2017) Anuradha Banerjee et al. NEURO-ONCOLOGY
- Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
- (2017) Yibing Yang et al. JNCI-Journal of the National Cancer Institute
- Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group
- (2016) Joann L. Ater et al. CANCER
- Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
- (2016) Alvaro Lassaletta et al. JOURNAL OF CLINICAL ONCOLOGY
- A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study
- (2015) Murali Chintagumpala et al. NEURO-ONCOLOGY
- The mTOR signaling pathway as a treatment target for intracranial neoplasms
- (2014) D. Pachow et al. NEURO-ONCOLOGY
- FINAL RESULTS OF A PROSPECTIVE MULTI-INSTITUTIONAL PHASE II STUDY OF EVEROLIMUS (RAD001), AN MTOR INHIBITOR, IN PEDIATRIC PATIENTS WITH RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA. A POETIC CONSORTIUM TRIAL
- (2014) M. W. Kieran et al. NEURO-ONCOLOGY
- Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
- (2014) M. A. Karajannis et al. NEURO-ONCOLOGY
- Long-term outcome of centrally located low-grade glioma in children
- (2013) Keita Terashima et al. CANCER
- The role of surgery in optic pathway/hypothalamic gliomas in children
- (2013) John Goodden et al. Journal of Neurosurgery-Pediatrics
- Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target
- (2013) Marianne Hütt-Cabezas et al. NEURO-ONCOLOGY
- Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
- (2013) A. J. Sievert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor suppressor functions of FBW7 in cancer development and progression
- (2012) Zhiwei Wang et al. FEBS LETTERS
- Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
- (2012) Joann L. Ater et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology
- (2012) A. K. Gnekow et al. NEURO-ONCOLOGY
- Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas
- (2012) Eugene I. Hwang et al. PEDIATRIC BLOOD & CANCER
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pediatric Low-Grade Gliomas
- (2009) Angela J. Sievert et al. JOURNAL OF CHILD NEUROLOGY
- Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival
- (2009) Sean M. McBride et al. JOURNAL OF NEURO-ONCOLOGY
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
- (2008) Stefan Pfister et al. JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started